Dakota Community Bank & Trust’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-540
Closed -$15K 107
2024
Q1
$15K Sell
540
-3,364
-86% -$93.3K 0.08% 89
2023
Q4
$112K Sell
3,904
-85
-2% -$2.57K 0.63% 58
2023
Q3
$132K Sell
3,989
-148
-4% -$5.23K 0.84% 47
2023
Q2
$152K Buy
4,137
+145
+4% +$5.64K 0.89% 39
2023
Q1
$163K Buy
3,992
+105
+3% +$4.54K 1.01% 37
2022
Q4
$199K Buy
3,887
+85
+2% +$4.08K 1.13% 30
2022
Q3
$166K Buy
+3,802
New +$185K 1.15% 38

Other funds holding PFE

Dakota Community Bank & Trust's PFE Position: Q2 2024 in Review

Dakota Community Bank & Trust sold out of Pfizer (PFE) in Q2 2024, closing a stake of 540 shares — an estimated $15K sold.

Dakota Community Bank & Trust first reported a position in PFE in Q3 2022 and held it in 7 quarters. The position peaked at $199K in Q4 2022. 2,874 funds tracked by Wall St. Rank hold PFE as of Q2 2024.

  • Dakota Community Bank & Trust reported no remaining Pfizer position as of Q2 2024 after selling out during the quarter.
  • Dakota Community Bank & Trust sold 540 Pfizer shares in Q2 2024, an estimated $15K.
  • Dakota Community Bank & Trust first reported a position in Pfizer in Q3 2022 and held it in 7 quarters.
  • Dakota Community Bank & Trust's Pfizer position peaked at $199K in Q4 2022.
  • 2,874 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.

Based on Dakota Community Bank & Trust's 13F filing for Q2 2024, filed 16 Jul 2024.